Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The Long-Term EVAR Assessment and Follow-Up (LEAF) Study for the AFX2 System

NCT: NCT06990048 · ACTIVE_NOT_RECRUITING

NCT IDNCT06990048
StatusACTIVE_NOT_RECRUITING
Start Date2023-09-21
Completion2027-05

Brief Summary

This is an observational, retrospective, multicenter study to evaluate the performance of the AFX2 System using real world evidence from VQI-VISION.

Frequently Asked Questions

What is The Long-Term EVAR Assessment and Follow-Up (LEAF) Study for the AFX2 System?

The Long-Term EVAR Assessment and Follow-Up (LEAF) Study for the AFX2 System is a clinical trial registered under NCT06990048. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT06990048?

The current status of NCT06990048 (The Long-Term EVAR Assessment and Follow-Up (LEAF) Study for the AFX2 System) is: ACTIVE_NOT_RECRUITING.

When did The Long-Term EVAR Assessment and Follow-Up (LEAF) Study for the AFX2 System start?

The Long-Term EVAR Assessment and Follow-Up (LEAF) Study for the AFX2 System started on 2023-09-21.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑